Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia
Vincenzo Savica1, Lorenzo A Calò, Paolo Monardo
1University of Messina, Messina, Italy. visavica@tin.it
Insights
Patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD) show higher salivary phosphate secretion. Serum phosphorus levels correlate with high-phosphate beverage consumption in hemodialysis (HD) patients.
Area of Science:
- Nephrology
- Internal Medicine
- Biochemistry
Background:
- Hyperphosphatemia is a dangerous complication of end-stage renal disease (ESRD).
- It is linked to cardiovascular calcification, increasing morbidity and mortality.
- Current treatments for hyperphosphatemia are insufficient, with only half of ESRD patients meeting K/DOQI guidelines.
Purpose of the Study:
- To investigate salivary phosphate secretion in hemodialysis (HD) and chronic kidney disease (CKD) patients.
- To analyze the beverage consumption habits of HD patients regarding phosphate content.
- To explore the correlation between hyperphosphatemia and beverage phosphate levels in HD patients.
Main Methods:
- Salivary phosphate secretion was measured in HD and CKD patients.
- Beverage consumption patterns, specifically phosphate content, were assessed in HD patients.
- Serum phosphorus levels were correlated with dietary phosphate intake from beverages.
Main Results:
- Elevated salivary phosphate secretion was observed in both HD and CKD patient groups.
- A significant relationship was found between serum phosphorus levels and the consumption of high-phosphate beverages among HD patients.
Conclusions:
- Increased salivary phosphate secretion is characteristic of HD and CKD patients.
- Dietary choices, particularly high-phosphate beverages, contribute to hyperphosphatemia in HD patients.
Background:
Hyperphosphatemia provides relevant and dangerous evidence of end-stage renal disease (ESRD) in patients undergoing periodic hemodialysis. The relationship between hyperphosphatemia and cardiovascular calcification, with the consequences of high morbidity and mortality after cardiovascular events, is well-defined. Hyperphosphatemia is treated by dietary limitation of phosphorus ingestion and by phosphate binders, but only half of ESRD patients fall within the range of K/DOQI guidelines.
Objective And Methods:
We summarize the results of our studies on salivary phosphate secretion in hemodialysis (HD) and chronic kidney disease (CKD) patients, and on the habit of HD patients to drink beverages with a high or low phosphate content. We also examine the correlation between hyperphosphoremia and the phosphate content of common beverages consumed by HD patients.
Results And Conclusions:
Higher levels of salivary phosphate secretion were found in HD and in CKD patients, along with a relationship between serum phosphorus levels and a high phosphate content of beverages in HD patients.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Introduction to Electrolytes
Role of Sodium
One...
Phosphate Buffer
Sodium dihydrogen phosphate does not fully dissociate in neutral or acidic solutions. When a strong base, such as sodium hydroxide (NaOH), is introduced into the solution, sodium dihydrogen phosphate...
Urinary Tract Calculi III: Medical Management


